PTH-Induced Bone Regeneration and Vascular Modulation Are Both Dependent on Endothelial Signaling

Area of Science:

• Orthopedics and Regenerative Medicine
• Endocrinology and Molecular Biology
• Vascular Biology

Background:

• Bone allografts are vital for nonunion fracture healing.
• Parathyroid hormone (PTH) therapy promotes allograft integration and angiogenesis.
• The role of endothelial PTH receptor-1 (PTHR1) in PTH-mediated bone healing is not fully understood.

Purpose of the Study:

• To investigate the dependence of PTH-induced osteogenesis and angiogenesis on endothelial PTHR1 signaling.
• To differentiate the roles of endothelial versus osteoblast PTHR1 signaling in bone healing.

Main Methods:

• Utilized transgenic mouse models including endothelial-specific PTHR1 knock-out and constitutively active PTHR1 mice.
• Employed calvarial allograft implantation and systemic PTH or PBS treatment.
• Assessed bone formation via micro-computed tomography and osteogenic activity using bioluminescence imaging (Oc-Luc mice).

Main Results:

• PTH-induced bone formation was abrogated in mice lacking endothelial PTHR1.
• Selective PTHR1 activation in osteoblasts yielded less bone formation than systemic PTH.
• Endothelial PTHR1 deletion impaired PTH-induced neovascularization, but osteoblast activation restored this effect.

Conclusions:

• Endothelial PTHR1 signaling is essential for PTH-driven osteogenesis and angiogenesis in bone allograft healing.
• PTHR1 in osteoblasts also contributes to bone formation, but endothelial signaling is critical for vascular modulation.
• Findings highlight the complex interplay of PTH signaling pathways in bone regeneration.